CD34 and central nervous system cancer: Other studies have used the featural patterns of radiomics to map different markers such as S-100, vimentin and CD34 expression patterns (specificities of 91%, 72% and 88%, respectively) and have further confirmed that glioma grading, as well as metastasis, can be accurately determined using radiomics [35,36,37].